« Scottish Enterprise Innovation Support | Main | Chief Operating Officer Appointed »
Tuesday
Jan032012

SMART:SCOTLAND Award

Aquila BioMedical is very pleased to announce the receipt of SMART:SCOTLAND funding for the purpose of developing the innovative MBP-tracker model. This technology will provide opportunity to the Pharmaceutical Industry to gain access to high value mechanism of action tools which will be relevant to the investigation of a range of T cell mediated autoimmune diseases, including Multiple Sclerosis. We look forward to discussing this with interested parties.

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>